Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-16
DOI
10.3389/fonc.2020.568557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Identifying multiple collagen gene family members as potential gastric cancer biomarkers using integrated bioinformatics analysis
- (2020) Zhaoxing Li et al. PeerJ
- Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14
- (2019) Tomohisa Okuno et al. ANNALS OF SURGICAL ONCOLOGY
- A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis
- (2019) Xinjian Guo et al. BMC CANCER
- An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
- (2019) Daniel Morgensztern et al. LUNG CANCER
- FGF Signalling in the Self-Renewal of Colon Cancer Organoids
- (2019) Jörg Otte et al. Scientific Reports
- First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors
- (2019) Takafumi Koyama et al. CANCER SCIENCE
- A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
- (2019) Li-Tzong Chen et al. Gastric Cancer
- CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells
- (2018) Yuichiro Miki et al. BRITISH JOURNAL OF CANCER
- Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
- (2018) Yasuhide Yamada et al. JOURNAL OF CLINICAL ONCOLOGY
- FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
- (2018) Jinglin Zhang et al. ONCOGENE
- Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
- (2018) Qiang Li et al. Cell Death & Disease
- 661PUpdated results from a phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated recurrent or refractory gastric cancer
- (2018) Y-J Bang et al. ANNALS OF ONCOLOGY
- A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors
- (2018) Eric Van Cutsem et al. CLINICAL CANCER RESEARCH
- Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)
- (2017) Hitoshi Katai et al. Gastric Cancer
- Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
- (2017) Hiroto Saito et al. Gastric Cancer
- Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells
- (2017) Takatsugu Ishimoto et al. GASTROENTEROLOGY
- FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1
- (2017) Tingting Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors
- (2017) Tomohiro Nishina et al. INVESTIGATIONAL NEW DRUGS
- Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
- (2017) Lucia Nogova et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Daniel V T Catenacci et al. LANCET ONCOLOGY
- FGF-dependent metabolic control of vascular development
- (2017) Pengchun Yu et al. NATURE
- Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours
- (2017) G Itoh et al. ONCOGENE
- A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
- (2017) Michael Michael et al. Targeted Oncology
- CXCL1–Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow–Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma
- (2016) Hiroaki Kasashima et al. AMERICAN JOURNAL OF PATHOLOGY
- E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models
- (2016) S. Watanabe Miyano et al. MOLECULAR CANCER THERAPEUTICS
- The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer
- (2016) Chuanli Ren et al. Oncotarget
- Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
- (2016) R. F. Sweis et al. Cancer Immunology Research
- FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells
- (2015) Chao Sun et al. BMC CANCER
- FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7
- (2015) Yu-Pan Bai et al. CANCER SCIENCE
- Lysyl oxidase is associated with the epithelial–mesenchymal transition of gastric cancer cells in hypoxia
- (2015) Hiroaki Kasashima et al. Gastric Cancer
- Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
- (2015) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion
- (2015) Sarah Knuchel et al. Oncotarget
- Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
- (2014) J.- C. Soria et al. ANNALS OF ONCOLOGY
- Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
- (2014) Hiroaki Kasashima et al. CANCER LETTERS
- Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion
- (2014) S. J. Coleman et al. EMBO Molecular Medicine
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Comparative Proteomics Analysis of Gastric Cancer Stem Cells
- (2014) Tamami Morisaki et al. PLoS One
- Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling
- (2013) Tsuyoshi Hasegawa et al. INTERNATIONAL JOURNAL OF CANCER
- FGF18 as a prognostic and therapeutic biomarker in ovarian cancer
- (2013) Wei Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
- (2013) Junko Matsuoka et al. PLoS One
- Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells
- (2012) Yuhiko Fuyuhiro et al. CANCER SCIENCE
- Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
- (2012) Valbona Luga et al. CELL
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
- (2012) Atsushi Nashimoto et al. Gastric Cancer
- FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
- (2012) V. Guagnano et al. Cancer Discovery
- Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
- (2011) Y Fuyuhiro et al. BRITISH JOURNAL OF CANCER
- Gastric linitis plastica: which role for surgical resection?
- (2011) Corrado Pedrazzani et al. Gastric Cancer
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
- (2011) D. Leali et al. MOLECULAR CANCER THERAPEUTICS
- Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to Extracellular Matrix Degradation
- (2010) N. Sugiyama et al. CANCER RESEARCH
- Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
- (2010) J. Webber et al. CANCER RESEARCH
- FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex
- (2010) N. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma
- (2009) H. Ando et al. BRITISH JOURNAL OF SURGERY
- Hereditary diffuse gastric cancer: A manifestation of lost cell polarity
- (2009) Bostjan Humar et al. CANCER SCIENCE
- Selective Killing of Hypoxia-Inducible Factor-1-Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
- (2009) S. Kizaka-Kondoh et al. CLINICAL CANCER RESEARCH
- Diffuse-Type Gastric Carcinoma: Progression, Angiogenesis, and Transforming Growth Factor β Signaling
- (2009) Akiyoshi Komuro et al. JNCI-Journal of the National Cancer Institute
- A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
- (2008) D. Sarker et al. CLINICAL CANCER RESEARCH
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started